Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
0.1230
0.00 (0.00%)
At close: Apr 17, 2025, 4:00 PM
0.1145
-0.0085 (-6.91%)
After-hours: Apr 17, 2025, 4:47 PM EDT

Spruce Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Net Income
-53.04-47.92-46.18-42.29-29.54
Upgrade
Depreciation & Amortization
0.050.070.070.070.04
Upgrade
Loss (Gain) From Sale of Assets
000.04--
Upgrade
Loss (Gain) From Sale of Investments
--0.640.020.12-
Upgrade
Stock-Based Compensation
5.354.623.633.960.76
Upgrade
Other Operating Activities
0.250.23-0.40.310.07
Upgrade
Change in Accounts Payable
-2.041.91-1.4-0.813.73
Upgrade
Change in Unearned Revenue
-4.914.91---
Upgrade
Change in Other Net Operating Assets
-1.623.542.532.76-2.57
Upgrade
Operating Cash Flow
-55.96-33.28-41.68-35.88-27.52
Upgrade
Capital Expenditures
--0.01-0.01-0.09-0.07
Upgrade
Investment in Securities
-55.7823.7-79.08-
Upgrade
Investing Cash Flow
-55.7823.69-79.17-0.07
Upgrade
Long-Term Debt Issued
---5-
Upgrade
Long-Term Debt Repaid
-1.62-1.62--4.77-
Upgrade
Net Debt Issued (Repaid)
-1.62-1.62-0.23-
Upgrade
Issuance of Common Stock
0.2553.790.080.4693.4
Upgrade
Repurchase of Common Stock
-0.25-0.31-0.04--
Upgrade
Other Financing Activities
--2.72-0.28-0.05-
Upgrade
Financing Cash Flow
-1.6249.14-0.240.64181.04
Upgrade
Net Cash Flow
-57.5971.64-18.23-114.4153.44
Upgrade
Free Cash Flow
-55.96-33.28-41.69-35.97-27.59
Upgrade
Free Cash Flow Margin
-1139.56%-329.88%---
Upgrade
Free Cash Flow Per Share
-1.36-0.86-1.77-1.54-4.61
Upgrade
Cash Interest Paid
0.230.370.270.210.19
Upgrade
Levered Free Cash Flow
-38.75-17.52-25.55-20.7-16.48
Upgrade
Unlevered Free Cash Flow
-38.56-17.22-25.28-20.49-16.28
Upgrade
Change in Net Working Capital
8.86-10.59-0.57-1.87-1.39
Upgrade
Updated Apr 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q